JJ
J&J post modest second quarter increase
July 21, 2010Sales and Marketing 2010 financials, J&J, JJ, Q2
Johnson & Johnson has seen a modest increase in sales for the second quarter, buoyed primarily by international sales and …
J&J cited by FDA for another manufacturing facility
July 20, 2010Manufacturing and Production J&J, JJ, manufacturing compliance
Another week, another raft of bad news for Johnson & Johnson’s manufacturing division. With one production facility already shut down …
J&J faces FDA scrutiny for another manufacturing unit
May 27, 2010Manufacturing and Production Advanced Sterilization Products, Ethicon, J&J, JJ, McNeil, manufacturing compliance
Another Johnson & Johnson subsidiary has come under scrutiny by FDA for failing to meet quality standards in its manufacturing. …
Pharma mergers and acquisitions in 2009
December 22, 2009Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review
This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …
J&J continues streamlining by cutting managers
November 11, 2009Sales and Marketing JJ, restructure
Johnson & Johnson has announced further restructuring that will see more than 8,000 jobs being cut.The conglomerate says that it …
Johnson & Johnson rides out patent attack
October 16, 2009Sales and Marketing JJ, generics
Profits at Johnson & Johnson have risen in the third quarter, despite deep cuts into pharma sales caused by new …
J&J buys stake in vaccines firm Crucell
September 29, 2009Sales and Marketing Crucell, JJ, vaccines
Johnson & Johnson has acquired an 18% stake in Netherlands-based vaccines firm Crucell, and the two companies will work together …
Janssen-Cilag wins NICE approval for psoriasis drug Stelara
September 23, 2009Sales and Marketing JJ, NICE, Stelara
NICE has approved Janssen-Cilag’s Stelara as a treatment option for adults with moderate to severe plaque psoriasis.Part of the process …
Johnson & Johnson to buy Cougar Biotechnology
May 27, 2009Research and Development, Sales and Marketing Cougar, J&J, JJ
Johnson & Johnson is to buy Los Angeles-based biotech firm Cougar Biotechnology for $970 million.The purchase, expected to go through …
Simponi approved in Canada
April 16, 2009Research and Development, Sales and Marketing J&J, JJ, Simponi
Johnson & Johnson's monoclonal antibody Simponi has been given regulatory approval in Canada.Simponi (golimumab) has been given the green light …
Johnson & Johnson appoints new global pharma chair
October 14, 2008Sales and Marketing JJ
Johnson & Johnson has named a new chairman for its struggling pharmaceuticals group, and kept the role under female leadership. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
